Ownership and insider activity for Cadrenal Therapeutics, Inc. Common Stock (CVKD): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
Cadrenal Therapeutics, Inc. operates as a biopharmaceutical enterprise primarily engaged in clinical development. The company's core focus is the advancement of Tecarfarin, a novel therapeutic agent that has received orphan drug designation. This treatment is engineered to prevent systemic thromboembolism originating from cardiac issues in patients suffering from both end-stage renal disease and atrial fibrillation.
Price
| Price | $1.08 |
| Market Cap | $4M |
| Exchange | NASDAQ |
| Country | US |
Balance Sheet (10y)
| Year | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Cash & Equivalents | $32586 | $8.4M | $10.0M | $4.0M |
| Short-term Investments | 0 | 0 | 0 | 0 |
| Receivables | 0 | $37248 | $38153 | $5096 |
| Inventory | 0 | 0 | 0 | 0 |
| Total Current Assets | $727596 | $8.5M | $10.1M | $4.3M |
| Property, Plant & Equipment | $44591 | $23285 | $6944 | $5174 |
| Goodwill | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 |
| Total Assets | $778174 | $8.5M | $10.1M | $4.3M |
| Accounts Payable | $404897 | $167319 | $1.5M | $650663 |
| Short-term Debt | $43728 | 0 | 0 | 0 |
| Total Current Liabilities | $1.3M | $826875 | $2.7M | $1.6M |
| Long-term Debt | $553340 | 0 | 0 | 0 |
| Total Liabilities | $6.3M | $826875 | $2.7M | $1.6M |
| Retained Earnings | -$6.7M | -$15.1M | -$25.7M | -$39.0M |
| Total Equity | -$5.6M | $7.7M | $7.4M | $2.7M |
| Total Debt | $640706 | $21350 | 0 | 0 |
| Net Debt | $608120 | -$8.4M | -$10.0M | -$4.0M |
| Working Capital | -$606881 | $7.7M | $7.4M | $2.7M |
Financial Health
| Debt / Equity | 0.00 |
| Current Ratio | 3.73 |
Profitability
| Return on Equity | -406.38% |
| Return on Invested Capital | -284.81% |
| Return on Assets | -206.55% |
| Gross Margin | 0.00% |
| Operating Margin | 0.00% |
| Net Margin | 0.00% |
Related companies: CLGN · IBIO · ITRM · KLTO · NRSN · NRXS · RLYB
Explore sector: Healthcare · Biotechnology
More sections of CVKD: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks